Ironwood Pharmaceuticals Inc.

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

In a filing, Ironwood Pharmaceuticals Inc revealed its Officer Davis Andrew acquired Company’s shares for reported $25030.0 on Nov 18

Stock Earnings

In a filing, Ironwood Pharmaceuticals Inc revealed its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

In a filing, Ironwood Pharmaceuticals Inc revealed its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Ironwood Pharmaceuticals Inc’s recent filing unveils that its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals

Analysts Viewpoint

Ironwood Pharmaceuticals Inc’s filing revealed that its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on Aug

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals

Tag: Ironwood Pharmaceuticals Inc.